
Cellectis enters an agreement with CELLforCURE for cGMP clinical manufacturing of allogeneic T-cells.

Cellectis enters an agreement with CELLforCURE for cGMP clinical manufacturing of allogeneic T-cells.

AMRI adds commercial-scale sterile injectable manufacturing capabilities with acquisition of Oso Biopharmaceuticals.

PacificGMP doubles its GMP production capacity with the addition of a second System 1000 Bioreactor platform.

PTSM: Pharmaceutical Technology Sourcing and Management
GE Healthcare introduces the Cytiva Plus Cardiomyocytes, a high fidelity human heart cell model.

PTSM: Pharmaceutical Technology Sourcing and Management
Rockland Immunochemicals develops new laboratories in Limerick, PA.

The 11th Annual Global Biomanufacturing Study includes a global analysis of 238 biomanufacturers and 178 suppliers in 31 countries.

EMD Millipore expands its Provantage upstream bioproduction services into North America.

Meissner moves into its new headquarters in Camarillo, California.

SGS makes two senior appointments at its new GMP/GLP laboratory in Carson, California.

Advanced Scientifics and Chemic Laboratories enter a three-year joint cooperation agreement to collaborate on product development projects.

KBI Biopharma acquires Merck's microbial process development and manufacturing operations in Colorado.

Gallus BioPharmaceuticals enters a cell line optimization and manufacturing agreement with Omni Bio Pharmaceutical.

At the request of FDA, the IOM prepared a report containing recommendations for how FDA might better monitor the safety of drugs after they have been approved.